A migraine is a headache that can cause severe throbbing pain or a pulsing sensation, usually on one side of the head. Migraine attacks can last hours or even days with pain can so severe that it ...

FDA Approves Symbravo for Acute Treatment of Migraine in Adults By Lori Solomon HealthDay Reporter WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved ...

Analysing the top 10 tech company logos, we can understand the art and science behind creating visual identities that stand out from the crowd. Most people scroll past logos like they're invisible.

Without a proper diagnosis, medications that can help reduce migraine may be delayed. Unfortunately, our study found racial and ethnic disparities in the diagnosis, testing and treatment of migraine." ...

Some scientific studies have suggested a link between migraine with aura and a patent foramen ovale (PFO), a relatively common congenital heart defect. With this postulated link, controversy arose ...

While migraine and severe migraine both refer to the same underlying neurological disorder, the key difference lies in the intensity, frequency, and impact of the attacks. While regular migraine ...

Qulipta (atogepant) is a brand-name drug prescribed for preventing migraine in adults. Qulipta comes as a tablet that’s typically taken once per day. The dosage can vary depending on the type of ...

Migraine with brainstem aura or MBA (formerly known as basilar migraines) are headaches that start in the lower part of the brain, called the brainstem. They cause symptoms such as dizziness ...

The pharmaceutical giant Pfizer will pay nearly $60 million to resolve charges that a company it acquired paid kickbacks so that physicians would prescribe a specific migraine drug to patients ...

In a 2017 review published in the journal Headache, scientists analyzed the results of five “gold standard” studies, in which magnesium supplements were given to one group of migraine patients ...

NEW YORK, Jan 24 (Reuters) - Pfizer (PFE.N), opens new tab will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs by paying kickbacks ...